Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 6,610 | 8,889 | 8,182 | 6,391 | 5,182 |
| Gross Profit | 6,610 | 8,889 | 8,182 | 6,391 | 5,182 |
| Operating Expenses | 63,988 | 49,557 | 95,462 | 52,485 | 121,808 |
| Operating Income | -57,378 | -40,668 | -87,280 | -46,094 | -116,626 |
| Other Income | 346 | 1,113 | 580 | 1,551 | 2,657 |
| Pre-tax Income | -57,032 | -39,555 | -86,700 | -44,543 | -113,969 |
| Net Income Continuous | -57,032 | -39,555 | -86,700 | -44,543 | -113,969 |
| Net Income | $-57,032 | $-39,555 | $-86,700 | $-44,543 | $-113,969 |
| EPS Basic Total Ops | -0.48 | -0.34 | -0.85 | -0.45 | -1.16 |
| EPS Basic Continuous Ops | -0.48 | -0.34 | -0.86 | -0.45 | -1.16 |
| EPS Diluted Total Ops | -0.48 | -0.34 | -0.85 | -0.45 | -1.16 |
| EPS Diluted Continuous Ops | -0.48 | -0.34 | -0.86 | -0.45 | -1.16 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.34 | -0.85 | -0.56 | -1.16 |
| EBITDA(a) | $-56,233 | $-39,644 | $-86,433 | $-45,369 | $-113,310 |